Clinical Report: Applying Glaucoma Strategies to AMD Care
Overview
Revise to better articulate the integration of functional testing in AMD management compared to glaucoma.
Background
Age-related macular degeneration (AMD) is a leading cause of vision loss among older adults, making effective diagnosis and management crucial. While structural imaging has advanced significantly in AMD care, functional testing remains underutilized. Adopting a more comprehensive approach that includes functional assessments could lead to better patient outcomes.
Data Highlights
No numerical data available in the source material.
Key Findings
- Functional testing, including contrast sensitivity (CS), dark adaptometry (DA), and microperimetry, is underutilized in AMD care.
- CS testing reveals the visual system's response to varying light and contrast, aiding in the detection of retinal health changes.
- DA can identify subclinical disease and predict conversion to advanced AMD before structural changes occur.
- Microperimetry assesses fixation and central visual field defects, providing insights into treatment effects.
- Combining structural imaging with functional testing may enhance the understanding of AMD progression.
Clinical Implications
Clinicians should consider incorporating functional testing into routine AMD assessments to improve early detection and monitoring of disease progression. This shift in practice could lead to more personalized treatment strategies and better patient outcomes.
Conclusion
Integrating functional testing into AMD care, akin to glaucoma management, represents a significant opportunity to enhance diagnostic accuracy and patient care. A change in clinical mindset is essential for realizing these benefits.
Related Resources & Content
- Age-Related Eye Disease Study Research Group, Am J Ophthalmol, 2001 -- The Age-Related Eye Disease Study system for classifying age-related macular degeneration
- Roark MW, Stringham JM, Mol Nutr Food Res, 2019 -- Visual performance in the “real world”: contrast sensitivity, visual acuity, and effects of macular carotenoids
- Kleiner RC et al., Arch Ophthalmol, 1988 -- Contrast sensitivity in age-related macular degeneration
- Higgins BE et al., Ophthalmol Ther, 2021 -- Are current methods of measuring dark adaptation effective in detecting the onset and progression of age-related macular degeneration?
- Owsley C et al., Ophthalmology, 2016 -- Delayed rod-mediated dark adaptation is a functional biomarker for incident early age-related macular degeneration
- Optometric Management — Geographic Atrophy: What Patients Need to Know
- Glaucoma Physician — Strategies for Successful Glaucoma Comanagement
- glaucoma physician — Strategies for Successful Glaucoma Comanagement
- Optometric Management — Applying AMD Diagnostics
- Geographic Atrophy: What Patients Need to Know
- Strategies for Successful Glaucoma Comanagement
- AAO 2025: Age-Related Macular Degeneration Guidelines
- Visual Field Examinations for Retinal Diseases: A Narrative Review - PMC
- Age-Related Macular Degeneration - Medical Clinical Policy Bulletins | Aetna
- Pegcetacoplan Treatment for Geographic Atrophy in Age-Related Macular Degeneration Over 36 Months: Data From OAKS, DERBY, and GALE - PubMed
- Avacincaptad Pegol for Geographic Atrophy Secondary to Age-Related Macular Degeneration: Two-Year Efficacy and Safety Results from the GATHER2 Phase 3 Trial - PubMed
- Intravitreal Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration: Ninety-Six-Week Results from the Randomized Phase 3 PULSAR Trial - ScienceDirect
- Retinal sensitivity changes in early/intermediate AMD: a systematic review and meta-analysis of visual field testing under mesopic and scotopic lighting | Eye
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.